{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:42:04Z","timestamp":1791607324243,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T00:00:00Z","timestamp":1465344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T00:00:00Z","timestamp":1465344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA160771"],"award-info":[{"award-number":["R01 CA160771"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","award":["P30 CA006973"],"award-info":[{"award-number":["P30 CA006973"]}],"id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rolf W. G\u00fcnther Foundation for Radiological Science","award":["Scholarship"],"award-info":[{"award-number":["Scholarship"]}]},{"DOI":"10.13039\/501100008336","name":"Gerhard C. Starck Foundation, D\u00fcsseldorf, Germany","doi-asserted-by":"crossref","award":["Scholarship"],"award-info":[{"award-number":["Scholarship"]}],"id":[{"id":"10.13039\/501100008336","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00330-016-4445-9","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T12:43:32Z","timestamp":1465389812000},"page":"526-535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization"],"prefix":"10.1007","volume":"27","author":[{"given":"Boris","family":"Gorodetski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger","family":"Schernthaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingDe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bareng Aletta Sanny","family":"Nonyane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily","family":"Pekurovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anobel","family":"Tamrazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Gebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Schlachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"key":"4445_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245\u20131255","journal-title":"Lancet"},{"key":"4445_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9\u201329","journal-title":"CA Cancer J Clin"},{"key":"4445_CR3","unstructured":"(2014) Global battle against cancer won't be won with treatment alone--effective prevention measures urgently needed to prevent cancer crisis. Cent Eur J Public Health 22:23, 28"},{"key":"4445_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329\u2013338","journal-title":"Semin Liver Dis"},{"key":"4445_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1477-2574.2010.00183.x","volume":"12","author":"RE Schwarz","year":"2010","unstructured":"Schwarz RE, Abou-Alfa GK, Geschwind JF et al (2010) Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement. HPB (Oxford) 12:313\u2013320","journal-title":"HPB (Oxford)"},{"key":"4445_CR6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M, American Association for the Study of Liver D (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020\u20131022","journal-title":"Hepatology"},{"key":"4445_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1586\/14737140.2013.845528","volume":"13","author":"J Chapiro","year":"2013","unstructured":"Chapiro J, Tacher V, Geschwind JF (2013) Intraarterial therapies for primary liver cancer: state of the art. Expert Rev Anticancer Ther 13:1157\u20131167","journal-title":"Expert Rev Anticancer Ther"},{"key":"4445_CR8","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","volume":"146","author":"T Yau","year":"2014","unstructured":"Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT (2014) Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology 146:1691\u20131700.e1693","journal-title":"Gastroenterology"},{"key":"4445_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390","journal-title":"N Engl J Med"},{"key":"4445_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nrgastro.2012.199","volume":"10","author":"A Villanueva","year":"2013","unstructured":"Villanueva A, Hernandez-Gea V, Llovet JM (2013) Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol 10:34\u201342","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4445_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-013-0654-7","author":"SP Kalva","year":"2013","unstructured":"Kalva SP, Pectasides M, Liu R et al (2013) Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma. Cardiovasc Intervent Radiol. doi:\n                    10.1007\/s00270-013-0654-7","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4445_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jvir.2012.11.026","volume":"24","author":"HJ Prajapati","year":"2013","unstructured":"Prajapati HJ, Dhanasekaran R, El-Rayes BF et al (2013) Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma. J Vasc Interv Radiol 24:307\u2013315","journal-title":"J Vasc Interv Radiol"},{"key":"4445_CR13","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1097\/01.RVI.0000182185.47500.7A","volume":"16","author":"CS Georgiades","year":"2005","unstructured":"Georgiades CS, Hong K, D'Angelo M, Geschwind JF (2005) Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 16:1653\u20131659","journal-title":"J Vasc Interv Radiol"},{"key":"4445_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1148\/radiol.10101058","volume":"258","author":"GE Chung","year":"2011","unstructured":"Chung GE, Lee JH, Kim HY et al (2011) Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival. Radiology 258:627\u2013634","journal-title":"Radiology"},{"key":"4445_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrgastro.2014.67","volume":"11","author":"J Chapiro","year":"2014","unstructured":"Chapiro J, Geschwind JF (2014) Hepatocellular carcinoma: have we finally found the ultimate staging system for HCC? Nat Rev Gastroenterol Hepatol 11:334\u2013336","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4445_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","volume":"33","author":"J Lammer","year":"2010","unstructured":"Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41\u201352","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4445_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/PPO.0b013e3181c5214b","volume":"15","author":"DK Reyes","year":"2009","unstructured":"Reyes DK, Vossen JA, Kamel IR et al (2009) Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J 15:526\u2013532","journal-title":"Cancer J"},{"key":"4445_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/cncr.24029","volume":"115","author":"T Yau","year":"2009","unstructured":"Yau T, Chan P, Ng KK et al (2009) Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response. Cancer 115:428\u2013436","journal-title":"Cancer"},{"key":"4445_CR19","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ejca.2011.12.006","volume":"48","author":"AL Cheng","year":"2012","unstructured":"Cheng AL, Guan Z, Chen Z et al (2012) Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial. Eur J Cancer 48:1452\u20131465","journal-title":"Eur J Cancer"},{"key":"4445_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","volume":"57","author":"J Bruix","year":"2012","unstructured":"Bruix J, Raoul JL, Sherman M et al (2012) Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol 57:821\u2013829","journal-title":"J Hepatol"},{"key":"4445_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3210-7","author":"J Edeline","year":"2015","unstructured":"Edeline J, Crouzet L, Campillo-Gimenez B et al (2015) Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis. Eur J Nucl Med Mol Imaging. doi:\n                    10.1007\/s00259-015-3210-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4445_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13098","author":"M de la Torre","year":"2016","unstructured":"de la Torre M, Buades-Mateu J, de la Rosa PA et al (2016) A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or Sorafenib. Liver Int. doi:\n                    10.1111\/liv.13098","journal-title":"Liver Int"},{"key":"4445_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/hep.21980","volume":"47","author":"LM Kulik","year":"2008","unstructured":"Kulik LM, Carr BI, Mulcahy MF et al (2008) Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47:71\u201381","journal-title":"Hepatology"},{"key":"4445_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","volume":"138","author":"R Salem","year":"2010","unstructured":"Salem R, Lewandowski RJ, Mulcahy MF et al (2010) Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 138:52\u201364","journal-title":"Gastroenterology"},{"key":"4445_CR25","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep.23944","volume":"52","author":"P Hilgard","year":"2010","unstructured":"Hilgard P, Hamami M, Fouly AE et al (2010) Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 52:1741\u20131749","journal-title":"Hepatology"},{"key":"4445_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jhep.2012.09.003","volume":"58","author":"K Memon","year":"2013","unstructured":"Memon K, Kulik L, Lewandowski RJ et al (2013) Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. J Hepatol 58:73\u201380","journal-title":"J Hepatol"},{"key":"4445_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2016.01.147","author":"DM Biederman","year":"2016","unstructured":"Biederman DM, Titano JJ, Tabori NE et al (2016) Outcomes of radioembolization in the treatment of hepatocellular carcinoma with portal vein invasion: resin versus glass microspheres. J Vasc Interv Radiol. doi:\n                    10.1016\/j.jvir.2016.01.147","journal-title":"J Vasc Interv Radiol"},{"key":"4445_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/cncr.24884","volume":"116","author":"BI Carr","year":"2010","unstructured":"Carr BI, Kondragunta V, Buch SC, Branch RA (2010) Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study. Cancer 116:1305\u20131314","journal-title":"Cancer"},{"key":"4445_CR29","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2087::AID-CNCR5>3.0.CO;2-M","volume":"79","author":"HS Lee","year":"1997","unstructured":"Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 79:2087\u20132094","journal-title":"Cancer"},{"key":"4445_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1245\/s10434-010-1321-8","volume":"18","author":"J Luo","year":"2011","unstructured":"Luo J, Guo RP, Lai EC et al (2011) Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study. Ann Surg Oncol 18:413\u2013420","journal-title":"Ann Surg Oncol"},{"key":"4445_CR31","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1007\/s12032-011-0145-0","volume":"29","author":"ZJ Niu","year":"2012","unstructured":"Niu ZJ, Ma YL, Kang P et al (2012) Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification. Med Oncol 29:2992\u20132997","journal-title":"Med Oncol"},{"key":"4445_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2214\/ajr.165.2.7618547","volume":"165","author":"JW Chung","year":"1995","unstructured":"Chung JW, Park JH, Han JK, Choi BI, Han MC (1995) Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJR Am J Roentgenol 165:315\u2013321","journal-title":"AJR Am J Roentgenol"},{"key":"4445_CR33","first-page":"194278","volume":"2014","author":"L Liu","year":"2014","unstructured":"Liu L, Zhang C, Zhao Y et al (2014) Transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis: prognostic factors in a single-center study of 188 patients. Biomed Res Int 2014:194278","journal-title":"Biomed Res Int"},{"key":"4445_CR34","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14131946:131946","author":"K Zhu","year":"2014","unstructured":"Zhu K, Chen J, Lai L et al (2014) Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib-A retrospective controlled study. Radiology. doi:\n                    10.1148\/radiol.14131946:131946","journal-title":"Radiology"},{"key":"4445_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-4198-x","author":"M Huang","year":"2016","unstructured":"Huang M, Lin Q, Wang H et al (2016) Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study. Eur Radiol. doi:\n                    10.1007\/s00330-015-4198-x","journal-title":"Eur Radiol"},{"key":"4445_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12657","author":"XL Li","year":"2016","unstructured":"Li XL, Guo WX, Hong XD et al (2016) Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis. Hepatol Res. doi:\n                    10.1111\/hepr.12657","journal-title":"Hepatol Res"},{"key":"4445_CR37","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1148\/rg.336125104","volume":"33","author":"SH McEvoy","year":"2013","unstructured":"McEvoy SH, McCarthy CJ, Lavelle LP et al (2013) Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the American Association for the Study of Liver Diseases. Radiographics 33:1653\u20131668","journal-title":"Radiographics"},{"key":"4445_CR38","unstructured":"Therneau T (2014) A package for survival analysis in S, pp R package version 2.37-37"},{"key":"4445_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0720-048X(03)00219-5","volume":"51","author":"J Uraki","year":"2004","unstructured":"Uraki J, Yamakado K, Nakatsuka A, Takeda K (2004) Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Eur J Radiol 51:12\u201318","journal-title":"Eur J Radiol"},{"key":"4445_CR40","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s00270-005-0171-4","volume":"29","author":"K Sato","year":"2006","unstructured":"Sato K, Lewandowski RJ, Bui JT et al (2006) Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 29:522\u2013529","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4445_CR41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/cbr.2012.1390","volume":"28","author":"O Pellerin","year":"2013","unstructured":"Pellerin O, Lin M, Bhagat N, Shao W, Geschwind JF (2013) Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis? Cancer Biother Radiopharm 28:459\u2013465","journal-title":"Cancer Biother Radiopharm"},{"key":"4445_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000329602","volume":"34","author":"H van Malenstein","year":"2011","unstructured":"van Malenstein H, Maleux G, Vandecaveye V et al (2011) A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma. Onkologie 34:368\u2013376","journal-title":"Onkologie"},{"key":"4445_CR43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","volume":"46","author":"M Varela","year":"2007","unstructured":"Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug-eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474\u2013481","journal-title":"J Hepatol"},{"key":"4445_CR44","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ejca.2008.02.018","volume":"44","author":"JH Wang","year":"2008","unstructured":"Wang JH, Changchien CS, Hu TH et al (2008) The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - survival analysis of 3892 patients. Eur J Cancer 44:1000\u20131006","journal-title":"Eur J Cancer"},{"key":"4445_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1051-0443(98)70273-8","volume":"9","author":"T de Baere","year":"1998","unstructured":"de Baere T, Denys A, Briquet R, Chevallier P, Dufaux J, Roche A (1998) Modification of arterial and portal hemodynamics after injection of iodized oils and different emulsions of iodized oils in the hepatic artery: an experimental study. J Vasc Interv Radiol 9:305\u2013310","journal-title":"J Vasc Interv Radiol"},{"key":"4445_CR46","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/00004424-199407000-00002","volume":"29","author":"Z Kan","year":"1994","unstructured":"Kan Z, Ivancev K, Lunderquist A (1994) Peribiliary plexa--important pathways for shunting of iodized oil and silicon rubber solution from the hepatic artery to the portal vein. An experimental study in rats. Investig Radiol 29:671\u2013676","journal-title":"Investig Radiol"},{"key":"4445_CR47","first-page":"1","volume":"408","author":"Z Kan","year":"1996","unstructured":"Kan Z (1996) Dynamic study of iodized oil in the liver and blood supply to hepatic tumors. An experimental investigation in several animal species. Acta Radiol Suppl 408:1\u201325","journal-title":"Acta Radiol Suppl"},{"key":"4445_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3348\/kjr.2009.10.5.425","volume":"10","author":"SW Shin","year":"2009","unstructured":"Shin SW (2009) The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 10:425\u2013434","journal-title":"Korean J Radiol"},{"key":"4445_CR49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1148\/radiol.12111550","volume":"263","author":"M Pinter","year":"2012","unstructured":"Pinter M, Hucke F, Graziadei I et al (2012) Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. Radiology 263:590\u2013599","journal-title":"Radiology"},{"key":"4445_CR50","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/MEG.0b013e3283386053","volume":"22","author":"V Ozenne","year":"2010","unstructured":"Ozenne V, Paradis V, Pernot S et al (2010) Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib. Eur J Gastroenterol Hepatol 22:1106\u20131110","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4445_CR51","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1148\/radiol.13131465","volume":"269","author":"RJ McDonald","year":"2013","unstructured":"McDonald RJ, McDonald JS, Kallmes DF, Carter RE (2013) Behind the numbers: propensity score analysis-a primer for the diagnostic radiologist. Radiology 269:640\u2013645","journal-title":"Radiology"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4445-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-016-4445-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4445-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4445-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:57:34Z","timestamp":1589630254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-016-4445-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,8]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4445"],"URL":"https:\/\/doi.org\/10.1007\/s00330-016-4445-9","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,8]]},"assertion":[{"value":"18 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}